FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319318416> ?p ?o ?g. }

• W4319318416 endingPage "1250" @default.
• W4319318416 startingPage "1250" @default.
• W4319318416 abstract "About 60% of cases of recurrent pregnancy loss have unexplained etiology. Immunotherapy for unexplained recurrent pregnancy loss is still unestablished. A 36-year-old woman, not obese, had a stillbirth at 22 gestational weeks and a spontaneous abortion at 8 weeks. She had been examined for recurrent pregnancy loss at previous clinics with no significant findings. When she visited our clinic, a hematologic test showed a Th1/Th2 ratio imbalance. Ultrasonography, hysteroscopy, and semen analysis showed no abnormalities. She successfully conceived by embryo transfer in hormone replacement therapy cycle. However, she had a miscarriage at 19 weeks. The baby had no deformities, but a chromosomal test was not performed, according to the parents’ will. The placenta pathologically suggested hemoperfusion problems. Her and her husband’s chromosomal tests showed normal karyotypes. Other examinations revealed a repeated Th1/Th2 ratio imbalance and a high resistance index of uterine radial artery blood flow. She was administered low-dose aspirin, intravenous immunoglobulin, and unfractionated heparin after the second embryo was transferred. Her baby was healthily born by cesarean section at 40 weeks. Intravenous immunoglobulin therapy can be a choice for recurrent miscarriage without risk factors because it has clinically beneficial influences on the patient’s immunological aberration." @default.
• W4319318416 created "2023-02-08" @default.
• W4319318416 creator A5018317647 @default.
• W4319318416 creator A5037449432 @default.
• W4319318416 creator A5041715889 @default.
• W4319318416 creator A5058076115 @default.
• W4319318416 creator A5065694141 @default.
• W4319318416 creator A5074658162 @default.
• W4319318416 creator A5082430691 @default.
• W4319318416 date "2023-02-04" @default.
• W4319318416 modified "2023-09-27" @default.
• W4319318416 title "Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review" @default.
• W4319318416 cites W1549417935 @default.
• W4319318416 cites W1643521391 @default.
• W4319318416 cites W1986150666 @default.
• W4319318416 cites W1998424689 @default.
• W4319318416 cites W2026472356 @default.
• W4319318416 cites W2038699236 @default.
• W4319318416 cites W2053626349 @default.
• W4319318416 cites W2092426441 @default.
• W4319318416 cites W2100592302 @default.
• W4319318416 cites W2106808598 @default.
• W4319318416 cites W2125359865 @default.
• W4319318416 cites W2144437930 @default.
• W4319318416 cites W2149298906 @default.
• W4319318416 cites W2213842625 @default.
• W4319318416 cites W2300021039 @default.
• W4319318416 cites W2567251402 @default.
• W4319318416 cites W2618376486 @default.
• W4319318416 cites W2626867668 @default.
• W4319318416 cites W2726030955 @default.
• W4319318416 cites W2755022299 @default.
• W4319318416 cites W2796224907 @default.
• W4319318416 cites W2896642427 @default.
• W4319318416 cites W2905754989 @default.
• W4319318416 cites W2949740467 @default.
• W4319318416 cites W2994826726 @default.
• W4319318416 cites W3035885449 @default.
• W4319318416 cites W3061340953 @default.
• W4319318416 cites W3123030064 @default.
• W4319318416 cites W3172312035 @default.
• W4319318416 cites W4238278966 @default.
• W4319318416 cites W4283688364 @default.
• W4319318416 cites W4312210519 @default.
• W4319318416 doi "https://doi.org/10.3390/jcm12041250" @default.
• W4319318416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36835786" @default.
• W4319318416 hasPublicationYear "2023" @default.
• W4319318416 type Work @default.
• W4319318416 citedByCount "0" @default.
• W4319318416 crossrefType "journal-article" @default.
• W4319318416 hasAuthorship W4319318416A5018317647 @default.
• W4319318416 hasAuthorship W4319318416A5037449432 @default.
• W4319318416 hasAuthorship W4319318416A5041715889 @default.
• W4319318416 hasAuthorship W4319318416A5058076115 @default.
• W4319318416 hasAuthorship W4319318416A5065694141 @default.
• W4319318416 hasAuthorship W4319318416A5074658162 @default.
• W4319318416 hasAuthorship W4319318416A5082430691 @default.
• W4319318416 hasBestOaLocation W43193184161 @default.
• W4319318416 hasConcept C131872663 @default.
• W4319318416 hasConcept C159654299 @default.
• W4319318416 hasConcept C203014093 @default.
• W4319318416 hasConcept C2778642596 @default.
• W4319318416 hasConcept C2779234561 @default.
• W4319318416 hasConcept C2779245376 @default.
• W4319318416 hasConcept C2780625311 @default.
• W4319318416 hasConcept C2909731803 @default.
• W4319318416 hasConcept C2909916134 @default.
• W4319318416 hasConcept C29456083 @default.
• W4319318416 hasConcept C46973012 @default.
• W4319318416 hasConcept C54355233 @default.
• W4319318416 hasConcept C71924100 @default.
• W4319318416 hasConcept C86803240 @default.
• W4319318416 hasConceptScore W4319318416C131872663 @default.
• W4319318416 hasConceptScore W4319318416C159654299 @default.
• W4319318416 hasConceptScore W4319318416C203014093 @default.
• W4319318416 hasConceptScore W4319318416C2778642596 @default.
• W4319318416 hasConceptScore W4319318416C2779234561 @default.
• W4319318416 hasConceptScore W4319318416C2779245376 @default.
• W4319318416 hasConceptScore W4319318416C2780625311 @default.
• W4319318416 hasConceptScore W4319318416C2909731803 @default.
• W4319318416 hasConceptScore W4319318416C2909916134 @default.
• W4319318416 hasConceptScore W4319318416C29456083 @default.
• W4319318416 hasConceptScore W4319318416C46973012 @default.
• W4319318416 hasConceptScore W4319318416C54355233 @default.
• W4319318416 hasConceptScore W4319318416C71924100 @default.
• W4319318416 hasConceptScore W4319318416C86803240 @default.
• W4319318416 hasIssue "4" @default.
• W4319318416 hasLocation W43193184161 @default.
• W4319318416 hasLocation W43193184162 @default.
• W4319318416 hasLocation W43193184163 @default.
• W4319318416 hasOpenAccess W4319318416 @default.
• W4319318416 hasPrimaryLocation W43193184161 @default.
• W4319318416 hasRelatedWork W2069772639 @default.
• W4319318416 hasRelatedWork W2095045775 @default.
• W4319318416 hasRelatedWork W2095808772 @default.
• W4319318416 hasRelatedWork W2202527093 @default.
• W4319318416 hasRelatedWork W2401739700 @default.
• W4319318416 hasRelatedWork W3015626588 @default.

• next